Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Avadel Pharmaceuticals (AVDL) stocks in Canada
Learn how to easily invest in Avadel Pharmaceuticals stocks.
Avadel Pharmaceuticals is a drug manufacturers-specialty & generic business based in the US. Avadel Pharmaceuticals stocks (AVDL.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.23 – a decrease of 1.97% over the previous week. Avadel Pharmaceuticals employs 32 staff and has a market cap (total outstanding stock value) of $337.1 million.
How to buy shares in Avadel Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AVDL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Avadel Pharmaceuticals?
- Has coronavirus impacted Avadel Pharmaceuticals shares?
- Avadel Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Avadel Pharmaceuticals stock a buy or sell?
- Avadel Pharmaceuticals performance over time
- Are Avadel Pharmaceuticals shares over-valued?
- Avadel Pharmaceuticals's financials
- How volatile are Avadel Pharmaceuticals shares?
- Does Avadel Pharmaceuticals pay a dividend?
- Other common questions
Avadel Pharmaceuticals stock price (NASDAQ:AVDL)Use our graph to track the performance of AVDL stocks over time.
Avadel Pharmaceuticals shares at a glance
|Latest market close||$5.46|
|52-week range||$4.93 - $11.59|
|50-day moving average||$8.11|
|200-day moving average||$8.19|
|Wall St. target price||$17.85|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.14|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Avadel Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Avadel Pharmaceuticals price performance over time
|1 week (2022-01-21)||-1.97%|
|1 month (2021-12-28)||-31.58%|
|3 months (2021-10-28)||-42.22%|
|6 months (2021-07-28)||-30.09%|
|1 year (2021-01-28)||-28.06%|
|2 years (2020-01-28)||-16.64%|
|3 years (2019-01-28)||141.59%|
|5 years (2017-01-27)||9.84|
Is Avadel Pharmaceuticals under- or over-valued?
Valuing Avadel Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avadel Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avadel Pharmaceuticals's PEG ratio
Avadel Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Avadel Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Avadel Pharmaceuticals financials
|Gross profit TTM||$16.6 million|
|Return on assets TTM||-16.21%|
|Return on equity TTM||-49.09%|
|Market capitalisation||$337.1 million|
TTM: trailing 12 months
Avadel Pharmaceuticals share dividends
We're not expecting Avadel Pharmaceuticals to pay a dividend over the next 12 months.
Avadel Pharmaceuticals share price volatility
Over the last 12 months, Avadel Pharmaceuticals's shares have ranged in value from as little as $4.93 up to $11.59. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avadel Pharmaceuticals's is 1.0841. This would suggest that Avadel Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Avadel Pharmaceuticals overview
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. .
Avadel Pharmaceuticals in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Silver Spike Investment Corp. (SSIC) stock in Canada when it goes public
Everything we know about the Silver Spike Investment Corp. IPO, plus information on how to buy in.
How to buy MOD Pizza stock in Canada when it goes public
Everything we know about the MOD Pizza IPO, plus information on how to buy in.
How to buy Modular Medical (MODD) stock in Canada when it goes public
Everything we know about the Modular Medical IPO, plus information on how to buy in.
How to buy Direct Digital Holdings (DRCT) stock in Canada when it goes public
Everything we know about the Direct Digital Holdings IPO, plus information on how to buy in.
How to buy TC BioPharm (TCBP) stock in Canada when it goes public
Everything we know about the TC BioPharm IPO, plus information on how to buy in.
How to buy Maris-Tech Ltd (MTEK) stock in Canada when it goes public
Everything we know about the Maris-Tech Ltd IPO, plus information on how to buy in.
How to buy Phoenix Motor (PEV) stock in Canada when it goes public
Everything we know about the Phoenix Motor IPO, plus information on how to buy in.
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.